Compare PW & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PW | AIDX |
|---|---|---|
| Founded | 1967 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.9M |
| IPO Year | 2011 | 2025 |
| Metric | PW | AIDX |
|---|---|---|
| Price | $6.51 | $0.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.8K | ★ 194.1K |
| Earning Date | 11-17-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.90 | 34.48 |
| EPS | N/A | ★ N/A |
| Revenue | $1,982,265.00 | ★ $2,045,133.00 |
| Revenue This Year | N/A | $44.20 |
| Revenue Next Year | N/A | $95.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.32 | ★ 16.71 |
| 52 Week Low | $0.50 | $0.21 |
| 52 Week High | $12.92 | $18.96 |
| Indicator | PW | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.65 | 27.37 |
| Support Level | $6.44 | N/A |
| Resistance Level | $7.76 | $0.69 |
| Average True Range (ATR) | 0.38 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 22.83 | 14.50 |
Power REIT is an internally-managed real estate investment trust that owns a portfolio of real estate assets related to transportation, energy infrastructure and Controlled Environment Agriculture in the United States. Its assets consisted of approximately 112 miles of railroad infrastructure and related real estate which is owned by its subsidiary, approximately 447 acres of fee simple land leased to a utility scale solar power generating project with an aggregate generating capacity of approximately 82 Megawatts and approximately 82 acres of land with approximately 357,000 square feet of CEA properties in the form of greenhouses. The company invested in greenhouses for state-licensed cannabis and food cultivation.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.